These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35100239)

  • 21. Individual Article: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne.
    Peterson H; Kircik L; Armstrong AW
    J Drugs Dermatol; 2023 Jun; 22(6):SF350992s7-SF350992s14. PubMed ID: 37276168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical inquiries. What is the best treatment for mild to moderate acne?
    Rao S; Malik MA; Wilder L; Mott T
    J Fam Pract; 2006 Nov; 55(11):994-6. PubMed ID: 17090362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clascoterone: A Novel Topical Androgen Receptor Inhibitor for the Treatment of Acne.
    Kalabalik-Hoganson J; Frey KM; Ozdener-Poyraz AE; Slugocki M
    Ann Pharmacother; 2021 Oct; 55(10):1290-1296. PubMed ID: 33533262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothalamic-Pituitary-Adrenal Axis Response in Patients With Acne Vulgaris Treated With Clascoterone.
    Bhatia N; Eichenfield LF; Mazzetti A; Moro L; Squittieri N; Hebert AA
    J Drugs Dermatol; 2024 Jun; 23(6):433-437. PubMed ID: 38834220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0·05% cream.
    Trifu V; Tiplica GS; Naumescu E; Zalupca L; Moro L; Celasco G
    Br J Dermatol; 2011 Jul; 165(1):177-83. PubMed ID: 21428978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of topical clascoterone cream for treatment of acne vulgaris: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Alkhodaidi ST; Al Hawsawi KA; Alkhudaidi IT; Magzoub D; Abu-Zaid A
    Dermatol Ther; 2021 Jan; 34(1):e14609. PubMed ID: 33258536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult Female Acne: Managing the Hormones.
    Lipson J
    Skin Therapy Lett; 2024 Jul; 29(4):5-7. PubMed ID: 38963912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of 1% Clascoterone Cream in Patients Aged > 12 Years With Acne Vulgaris.
    Hebert A; Eichenfield L; Thiboutot D; Stein Gold L; Vassileva S; Mihaylova Y; Cartwright M; Moro L; Fragasso E; Han J; Squittieri N; Mazzetti A
    J Drugs Dermatol; 2023 Feb; 22(2):174-181. PubMed ID: 36745367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of in vitro Skin Permeation of Clascoterone From Clascoterone Topical Cream, 1% (w/w).
    Yang Y; Wang J; Wanasathop A; Niu M; Ghosh P; Zidan A; Gu J; Hunt R; Faustino P; Ashraf M; Xu X
    AAPS PharmSciTech; 2024 Aug; 25(6):186. PubMed ID: 39138712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Game Changer in Acne Treatment.
    Kircik LH
    J Drugs Dermatol; 2020 Mar; 19(3):28. PubMed ID: 32550698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist.
    Kircik LH
    Expert Opin Pharmacother; 2021 Sep; 22(13):1801-1806. PubMed ID: 33906537
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of hormonal agents in the treatment of acne.
    Hassoun LA; Chahal DS; Sivamani RK; Larsen LN
    Semin Cutan Med Surg; 2016 Jun; 35(2):68-73. PubMed ID: 27416311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination topical therapy in the treatment of acne.
    Del Rosso JQ
    Cutis; 2006 Aug; 78(2 Suppl 1):5-12. PubMed ID: 17966494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne Vulgaris.
    Eichenfield LF; Gold LS; Han J; Hebert AA; Mazzetti A; Moro L; Squittieri N; Thiboutot D
    J Drugs Dermatol; 2024 Jan; 23(1):1278-1283. PubMed ID: 38206145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azelaic acid 20% cream (AZELEX) and the medical management of acne vulgaris.
    Gibson JR
    Dermatol Nurs; 1997 Oct; 9(5):339-44. PubMed ID: 9392765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clascoterone: How the Novel Androgen Receptor Inhibitor Fits Into the Acne Treatment Paradigm.
    Purvis CG; Balogh EA; Feldman SR
    Ann Pharmacother; 2021 Oct; 55(10):1297-1299. PubMed ID: 33543640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Class of Topical Acne Treatment Addressing the Hormonal Pathogenesis of Acne.
    Barbieri JS
    JAMA Dermatol; 2020 Jun; 156(6):619-620. PubMed ID: 32320045
    [No Abstract]   [Full Text] [Related]  

  • 38. AKLIEF (Trifarotene 0.005% [50 μg/g] Cream) for Topical Treatment of Acne Vulgaris.
    Gupta AK; Bruce A; Abramovits W; Vincent KD
    Skinmed; 2020; 18(3):160-163. PubMed ID: 32790612
    [No Abstract]   [Full Text] [Related]  

  • 39. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroids Used to Treat Acne Vulgaris: A Review of Efficacy, Safety, and Clinical Considerations.
    Cantrell W; Easley L; Squittieri K
    J Drugs Dermatol; 2024 Jun; 23(6):404-409. PubMed ID: 38834219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.